Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies
The oncologist (Dayton, Ohio), 2023-06, Vol.28 (6), p.e487-e487 [Peer Reviewed Journal]The Author(s) 2023. Published by Oxford University Press. 2023 ;COPYRIGHT 2023 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad048 ;PMID: 36821849
Full text available